Premium
Anticholinergic‐induced chorea in the treatment of focal dystonia
Author(s) -
Nomoto M.,
Thompson P. D.,
Sheehy M. P.,
Quinn N. P.,
Marsden C. D.
Publication year - 1987
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.870020107
Subject(s) - trihexyphenidyl , chorea , dystonia , anticholinergic , medicine , anesthesia , focal dystonia , neurological disorder , movement disorders , confusion , ataxia , pediatrics , psychology , surgery , central nervous system disease , psychiatry , disease , psychoanalysis
The occurrence of chorea, induced by trihexyphenidyl (benzhexol hydrochloride) during the treatment of five adult patients who had focal or segmental dystonia, is described. The dose at which chorea appeared ranged from 15 to 60 mg/day (mean 31.7 mg/day). All but one patient had developed common adverse effects of this drug (dry mouth, blurred vision, and confusion) at lower doses (mean 21.8 mg per day). There was an inverse relationship between the age of the patient and the dose of trihexyphenidyl at which chorea developed.